These findings are concordant with available literature, demonstrating that elevated inflammation marker (eg. CRP) is associated with increased risk of ILD in SSc, idiopathic inflammatory myopathy or Sjögren’s disease,25 32 33 but also with prognosis/long-term progression.34 35. This evidence concerns the gene CRP and interstitial lung disease.